Found 2207 hits with Last Name = 'koch' and Initial = 't' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469350
(US10807988, Example SC_3001 | cis-5-[1-(Cyclobutyl...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(C(=O)N2CC2CCC2)c2cnc(nc2)C#N)CC1)c1ccccc1 |r,wU:6.11,3.2,(6.58,22.67,;5.1,23.06,;4.7,24.55,;4.01,21.98,;3.24,20.64,;1.7,20.64,;.93,21.98,;.02,23.22,;-1.44,22.75,;-1.44,21.21,;-2.69,20.3,;.02,20.73,;.5,19.26,;-.53,18.12,;-2.07,18.12,;-2.07,16.58,;-.53,16.58,;-2.69,23.65,;-2.53,25.18,;-3.77,26.09,;-5.18,25.46,;-5.34,23.93,;-4.1,23.02,;-6.43,26.37,;-7.67,27.27,;1.7,23.31,;3.24,23.31,;5.1,20.89,;4.7,19.4,;5.79,18.31,;7.27,18.71,;7.67,20.2,;6.58,21.28,)| Show InChI InChI=1S/C26H32N6O/c1-30(2)26(21-9-4-3-5-10-21)13-11-25(12-14-26)19-31(22-16-28-23(15-27)29-17-22)24(33)32(25)18-20-7-6-8-20/h3-5,9-10,16-17,20H,6-8,11-14,18-19H2,1-2H3/t25-,26+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
| US Patent
| 0.300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Grünenthal GmbH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 mM M... |
US Patent US10807988 (2020)
BindingDB Entry DOI: 10.7270/Q25Q5060 |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM464662
(CIS-1-(Cyclopropyl-methyl)-8-dimethylamino-8-pheny...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(CC(C)(C)N3CCCS3(=O)=O)C(=O)N2CC2(O)CCC2)CC1)c1ccccc1 |r,wU:6.23,3.2,(5.39,-23.23,;3.85,-23.23,;3.08,-21.9,;3.08,-24.57,;2.31,-25.9,;.77,-25.9,;-0,-24.57,;-.91,-23.32,;-2.37,-23.8,;-3.71,-23.03,;-5.04,-23.8,;-5.81,-25.13,;-4.27,-25.13,;-6.37,-23.03,;-7.84,-23.5,;-8.74,-22.26,;-7.84,-21.01,;-6.37,-21.49,;-6.37,-19.95,;-4.89,-21.09,;-2.37,-25.34,;-3.62,-26.24,;-.91,-25.81,;-.43,-27.28,;-1.46,-28.42,;.03,-28.82,;-3,-28.42,;-3,-29.96,;-1.46,-29.96,;.77,-23.23,;2.31,-23.23,;3.85,-25.9,;3.08,-27.23,;3.85,-28.57,;5.39,-28.57,;6.16,-27.23,;5.39,-25.9,)| Show InChI InChI=1S/C28H44N4O4S/c1-25(2,32-18-9-19-37(32,35)36)20-30-21-26(31(24(30)33)22-27(34)12-8-13-27)14-16-28(17-15-26,29(3)4)23-10-6-5-7-11-23/h5-7,10-11,34H,8-9,12-22H2,1-4H3/t26-,28+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.400 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRUENENTHAL GMBH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 mM M... |
US Patent US10793556 (2020)
BindingDB Entry DOI: 10.7270/Q2XK8JMK |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469352
(US10807988, Example SC_3003 | cis-5-[1-(Cyclobutyl...)Show SMILES COc1nc(ncc1N1C[C@]2(CC[C@@](CC2)(N(C)C)c2ccccc2)N(CC2CCC2)C1=O)C#N |r,wU:10.27,13.17,(-.93,-.89,;-.93,-2.43,;-2.26,-3.2,;-3.6,-2.43,;-4.93,-3.2,;-4.93,-4.74,;-3.6,-5.51,;-2.26,-4.74,;-.93,-5.51,;.53,-5.03,;1.44,-6.28,;2.21,-7.61,;3.75,-7.61,;4.52,-6.28,;3.75,-4.94,;2.21,-4.94,;5.29,-4.94,;6.83,-4.94,;4.52,-3.61,;5.29,-7.61,;4.52,-8.95,;5.29,-10.28,;6.83,-10.28,;7.6,-8.95,;6.83,-7.61,;.53,-7.52,;1.01,-8.99,;-.02,-10.13,;-1.56,-10.13,;-1.56,-11.67,;-.02,-11.67,;-.93,-7.05,;-2.18,-7.95,;-6.27,-2.43,;-7.6,-1.66,)| Show InChI InChI=1S/C27H34N6O2/c1-31(2)27(21-10-5-4-6-11-21)14-12-26(13-15-27)19-32(25(34)33(26)18-20-8-7-9-20)22-17-29-23(16-28)30-24(22)35-3/h4-6,10-11,17,20H,7-9,12-15,18-19H2,1-3H3/t26-,27+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.400 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Grünenthal GmbH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 mM M... |
US Patent US10807988 (2020)
BindingDB Entry DOI: 10.7270/Q25Q5060 |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469875
(CIS-2-[1-(Cyclobutyl-methyl)-8-dimethylamino-2-oxo...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(CC(=O)NCc3ccccc3C)C(=O)N2CC2CCC2)CC1)c1ccccc1 |r,wU:6.24,3.2,(-7.28,-9.36,;-6.19,-10.44,;-4.7,-10.05,;-6.59,-11.93,;-6.59,-13.47,;-7.92,-14.24,;-9.26,-13.47,;-10.55,-12.63,;-11.75,-13.6,;-13.23,-13.2,;-14.32,-14.29,;-13.92,-15.78,;-15.81,-13.89,;-16.9,-14.98,;-18.39,-14.58,;-19.47,-15.67,;-20.96,-15.27,;-21.36,-13.79,;-20.27,-12.7,;-18.78,-13.1,;-17.7,-12.01,;-11.19,-15.04,;-11.96,-16.37,;-9.66,-14.96,;-8.57,-16.05,;-8.97,-17.54,;-10.3,-18.31,;-9.53,-19.64,;-8.2,-18.87,;-9.26,-11.93,;-7.92,-11.16,;-5.1,-12.33,;-4.7,-13.82,;-3.22,-14.22,;-2.13,-13.13,;-2.53,-11.64,;-4.01,-11.24,)| Show InChI InChI=1S/C31H42N4O2/c1-24-10-7-8-13-26(24)20-32-28(36)22-34-23-30(35(29(34)37)21-25-11-9-12-25)16-18-31(19-17-30,33(2)3)27-14-5-4-6-15-27/h4-8,10,13-15,25H,9,11-12,16-23H2,1-3H3,(H,32,36)/t30-,31+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.400 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRÜNENTHAL GMBH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl, 10 mM M... |
US Patent US10807989 (2020)
BindingDB Entry DOI: 10.7270/Q2222XTM |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469376
(US10807988, Example SC_3022 | cis-1-(Cyclobutyl-me...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(C(=O)N2CC2CCC2)c2cnc(nc2)C(F)(F)F)CC1)c1ccccc1 |r,wU:6.11,3.2,(4.39,8.81,;5.16,7.47,;6.7,7.47,;4.39,6.14,;3.62,4.81,;2.08,4.81,;1.31,6.14,;.41,7.38,;-1.06,6.91,;-1.06,5.37,;-2.31,4.46,;.41,4.89,;.88,3.43,;-.15,2.28,;-1.69,2.28,;-1.69,.74,;-.15,.74,;-2.39,7.68,;-2.39,9.22,;-3.73,9.99,;-5.06,9.22,;-5.06,7.68,;-3.73,6.91,;-6.39,9.99,;-7.73,9.22,;-6.39,11.53,;-7.73,10.76,;2.08,7.47,;3.62,7.47,;5.16,4.81,;4.39,3.47,;5.16,2.14,;6.7,2.14,;7.47,3.47,;6.7,4.81,)| Show InChI InChI=1S/C26H32F3N5O/c1-32(2)25(20-9-4-3-5-10-20)13-11-24(12-14-25)18-33(23(35)34(24)17-19-7-6-8-19)21-15-30-22(31-16-21)26(27,28)29/h3-5,9-10,15-16,19H,6-8,11-14,17-18H2,1-2H3/t24-,25+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.400 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Grünenthal GmbH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 mM M... |
US Patent US10807988 (2020)
BindingDB Entry DOI: 10.7270/Q25Q5060 |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469999
(CIS-2-[1-(Cyclobutyl-methyl)-8-dimethylamino-2-oxo...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(CC(=O)Nc3cncnc3)C(=O)N2CC2CCC2)CC1)c1ccccc1 |r,wU:6.22,3.2,(-4.1,21.01,;-5.59,21.41,;-5.99,22.9,;-6.68,20.32,;-7.45,18.99,;-8.99,18.99,;-9.76,20.32,;-10.67,21.57,;-12.13,21.09,;-13.22,22.18,;-14.71,21.78,;-15.11,20.3,;-15.8,22.87,;-17.28,22.47,;-17.68,20.99,;-19.17,20.59,;-20.26,21.68,;-19.86,23.16,;-18.37,23.56,;-12.13,19.55,;-13.46,18.78,;-10.67,19.08,;-9.9,17.74,;-10.67,16.41,;-12.15,16.01,;-11.76,14.52,;-10.27,14.92,;-8.99,21.66,;-7.45,21.66,;-5.59,19.23,;-5.99,17.75,;-4.9,16.66,;-3.41,17.06,;-3.02,18.54,;-4.1,19.63,)| Show InChI InChI=1S/C27H36N6O2/c1-31(2)27(22-9-4-3-5-10-22)13-11-26(12-14-27)19-32(25(35)33(26)17-21-7-6-8-21)18-24(34)30-23-15-28-20-29-16-23/h3-5,9-10,15-16,20-21H,6-8,11-14,17-19H2,1-2H3,(H,30,34)/t26-,27+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRÜNENTHAL GMBH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl, 10 mM M... |
US Patent US10807989 (2020)
BindingDB Entry DOI: 10.7270/Q2222XTM |
More data for this
Ligand-Target Pair | |
Mu-type opioid receptor
(Homo sapiens (Human)) | BDBM472033
(US10829480, Example SC_2061)Show SMILES CN(C)[C@]1(CC[C@]2(CN(Cc3cccnc3)C(=O)N2CC2CCC2)CC1)c1ccccc1 |r,wU:6.19,3.2,(-9.65,-1.19,;-8.88,-2.52,;-7.34,-2.52,;-9.65,-3.86,;-10.42,-5.19,;-11.96,-5.19,;-12.73,-3.86,;-13.63,-2.61,;-15.09,-3.09,;-16.43,-2.32,;-17.76,-3.09,;-19.1,-2.32,;-20.43,-3.09,;-20.43,-4.63,;-19.1,-5.4,;-17.76,-4.63,;-15.09,-4.63,;-16.43,-5.4,;-13.63,-5.1,;-13.23,-6.59,;-14.32,-7.68,;-15.86,-7.68,;-15.86,-9.22,;-14.32,-9.22,;-11.96,-2.52,;-10.42,-2.52,;-8.88,-5.19,;-9.65,-6.52,;-8.88,-7.86,;-7.34,-7.86,;-6.57,-6.52,;-7.34,-5.19,)| Show InChI InChI=1S/C27H36N4O/c1-29(2)27(24-11-4-3-5-12-24)15-13-26(14-16-27)21-30(19-23-10-7-17-28-18-23)25(32)31(26)20-22-8-6-9-22/h3-5,7,10-12,17-18,22H,6,8-9,13-16,19-21H2,1-2H3/t26-,27+ | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRUENENTHAL GMBH
US Patent
| Assay Description
Mu-Opioid Peptide (hMOP): The hMOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buff... |
US Patent US10829480 (2020)
BindingDB Entry DOI: 10.7270/Q2SB48SB |
More data for this
Ligand-Target Pair | |
Prepronociceptin
(Human) | BDBM464503
(US10793528, Example SC_5078)Show SMILES CN(C)[C@]1(CC[C@]2(CN(CC(C)(C)C(N)=O)C(=O)N2CC2(CCC2)C#N)CC1)c1ccccc1 |r,wU:6.18,3.2,(4.48,3.79,;4.48,2.25,;5.9,1.66,;3.39,1.16,;2.62,-.18,;1.08,-.18,;.31,1.16,;-.59,2.4,;-2.06,1.93,;-3.39,2.7,;-4.73,1.93,;-5.5,.59,;-3.96,.59,;-6.06,2.7,;-7.39,1.93,;-6.06,4.24,;-2.06,.39,;-3.3,-.52,;-.59,-.09,;-.12,-1.55,;-1.15,-2.7,;-2.69,-2.7,;-2.69,-4.24,;-1.15,-4.24,;.34,-3.1,;1.83,-3.49,;1.08,2.49,;2.62,2.49,;4.73,.39,;4.73,-1.15,;6.06,-1.92,;7.39,-1.15,;7.39,.39,;6.06,1.16,)| Show InChI InChI=1S/C27H39N5O2/c1-24(2,22(29)33)18-31-20-26(32(23(31)34)19-25(17-28)11-8-12-25)13-15-27(16-14-26,30(3)4)21-9-6-5-7-10-21/h5-7,9-10H,8,11-16,18-20H2,1-4H3,(H2,29,33)/t26-,27+ | UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRÜNENTHAL GMBH
US Patent
| Assay Description
NOP:The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 ... |
US Patent US10793528 (2020)
BindingDB Entry DOI: 10.7270/Q2Q243B2 |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469382
(US10807988, Example SC_3028 | cis-4-[1-(Cyclobutyl...)Show SMILES CN(C)C(=O)c1ccc(cc1)N1C[C@]2(CC[C@@](CC2)(N(C)C)c2ccccc2)N(CC2CCC2)C1=O |r,wU:13.30,16.20,(-8.08,-16.17,;-6.84,-17.07,;-7,-18.61,;-5.43,-16.45,;-5.27,-14.92,;-4.18,-17.35,;-2.78,-16.73,;-1.53,-17.63,;-1.69,-19.16,;-3.1,-19.79,;-4.35,-18.89,;-.45,-20.07,;1.02,-19.59,;1.92,-20.84,;2.69,-22.17,;4.23,-22.17,;5,-20.84,;4.23,-19.51,;2.69,-19.51,;5.77,-19.51,;5,-18.17,;7.31,-19.51,;5.77,-22.17,;5,-23.51,;5.77,-24.84,;7.31,-24.84,;8.08,-23.51,;7.31,-22.17,;1.02,-22.09,;1.49,-23.55,;.46,-24.69,;-1.08,-24.69,;-1.08,-26.23,;.46,-26.23,;-.45,-21.61,;-1.69,-22.51,)| Show InChI InChI=1S/C30H40N4O2/c1-31(2)27(35)24-13-15-26(16-14-24)33-22-29(34(28(33)36)21-23-9-8-10-23)17-19-30(20-18-29,32(3)4)25-11-6-5-7-12-25/h5-7,11-16,23H,8-10,17-22H2,1-4H3/t29-,30+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.600 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Grünenthal GmbH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 mM M... |
US Patent US10807988 (2020)
BindingDB Entry DOI: 10.7270/Q25Q5060 |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469357
(US10807988, Example SC_3008 | cis-2-[1-(Cyclobutyl...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(C(=O)N2CC2CCC2)c2ccc(cc2C#N)S(C)(=O)=O)CC1)c1ccccc1 |r,wU:6.11,3.2,(6.57,-21.14,;5.03,-21.14,;4.26,-19.81,;4.26,-22.47,;3.49,-23.81,;1.95,-23.81,;1.18,-22.47,;.28,-21.23,;-1.19,-21.7,;-1.19,-23.24,;-2.43,-24.15,;.28,-23.72,;.75,-25.19,;-.28,-26.33,;-1.82,-26.33,;-1.82,-27.87,;-.28,-27.87,;-2.43,-20.8,;-3.84,-21.43,;-5.08,-20.52,;-4.92,-18.99,;-3.52,-18.36,;-2.27,-19.27,;-.86,-18.64,;.54,-18.02,;-6.17,-18.08,;-7.58,-18.71,;-6.94,-16.75,;-5.08,-17,;1.95,-21.14,;3.49,-21.14,;5.03,-23.81,;4.26,-25.14,;5.03,-26.48,;6.57,-26.48,;7.34,-25.14,;6.57,-23.81,)| Show InChI InChI=1S/C29H36N4O3S/c1-31(2)29(24-10-5-4-6-11-24)16-14-28(15-17-29)21-32(27(34)33(28)20-22-8-7-9-22)26-13-12-25(37(3,35)36)18-23(26)19-30/h4-6,10-13,18,22H,7-9,14-17,20-21H2,1-3H3/t28-,29+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.600 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Grünenthal GmbH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 mM M... |
US Patent US10807988 (2020)
BindingDB Entry DOI: 10.7270/Q25Q5060 |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469435
(US10807988, Example SC_3076 | cis-1-(Cyclobutyl-me...)Show SMILES COc1ncc(cn1)N1C[C@]2(CC[C@@](CC2)(N(C)C)c2ccccc2)N(CC2CCC2)C1=O |r,wU:10.27,13.17,(-7.19,-2.27,;-5.7,-1.87,;-4.62,-2.96,;-3.13,-2.56,;-2.04,-3.65,;-2.44,-5.14,;-3.93,-5.54,;-5.01,-4.45,;-1.35,-6.23,;.12,-5.75,;1.02,-7,;1.79,-8.33,;3.33,-8.33,;4.1,-7,;3.33,-5.66,;1.79,-5.66,;4.87,-5.66,;4.1,-4.33,;6.41,-5.66,;4.87,-8.33,;4.1,-9.67,;4.87,-11,;6.41,-11,;7.18,-9.67,;6.41,-8.33,;.12,-8.24,;.59,-9.71,;-.44,-10.85,;-1.98,-10.85,;-1.98,-12.39,;-.44,-12.39,;-1.35,-7.77,;-2.59,-8.67,)| Show InChI InChI=1S/C26H35N5O2/c1-29(2)26(21-10-5-4-6-11-21)14-12-25(13-15-26)19-30(22-16-27-23(33-3)28-17-22)24(32)31(25)18-20-8-7-9-20/h4-6,10-11,16-17,20H,7-9,12-15,18-19H2,1-3H3/t25-,26+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.600 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Grünenthal GmbH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 mM M... |
US Patent US10807988 (2020)
BindingDB Entry DOI: 10.7270/Q25Q5060 |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469437
(US10807988, Example SC_3078 | cis-5-[1-(Cyclobutyl...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(C(=O)N2CC2CCC2)c2cnc(cc2C)C#N)CC1)c1ccccc1 |r,wU:6.11,3.2,(4.01,24.08,;4.78,22.75,;6.32,22.75,;4.01,21.41,;3.24,20.08,;1.7,20.08,;.93,21.41,;.03,22.66,;-1.44,22.18,;-1.44,20.64,;-2.68,19.74,;.03,20.17,;.5,18.7,;-.53,17.56,;-2.07,17.56,;-2.07,16.02,;-.53,16.02,;-2.53,23.27,;-4.01,22.87,;-5.1,23.96,;-4.7,25.45,;-3.22,25.85,;-2.13,24.76,;-.64,25.16,;-5.79,26.54,;-6.88,27.63,;1.7,22.75,;3.24,22.75,;4.78,20.08,;4.01,18.74,;4.78,17.41,;6.32,17.41,;7.09,18.74,;6.32,20.08,)| Show InChI InChI=1S/C28H35N5O/c1-21-16-24(17-29)30-18-25(21)32-20-27(33(26(32)34)19-22-8-7-9-22)12-14-28(15-13-27,31(2)3)23-10-5-4-6-11-23/h4-6,10-11,16,18,22H,7-9,12-15,19-20H2,1-3H3/t27-,28+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.600 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Grünenthal GmbH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 mM M... |
US Patent US10807988 (2020)
BindingDB Entry DOI: 10.7270/Q25Q5060 |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469354
(US10807988, Example SC_3005 | cis-5-[1-(Cyclobutyl...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(C(=O)N2CC2CCC2)c2cnc(nc2)C(N)=O)CC1)c1ccccc1 |r,wU:6.11,3.2,(6.39,21.95,;4.9,22.35,;4.5,23.83,;3.81,21.26,;3.04,19.92,;1.5,19.92,;.73,21.26,;-.17,22.5,;-1.64,22.03,;-1.64,20.49,;-2.88,19.58,;-.17,20.01,;.31,18.55,;-.73,17.4,;-2.27,17.4,;-2.27,15.86,;-.73,15.86,;-2.72,23.12,;-2.33,24.6,;-3.41,25.69,;-4.9,25.29,;-5.3,23.81,;-4.21,22.72,;-5.99,26.38,;-5.59,27.87,;-7.48,25.98,;1.5,22.59,;3.04,22.59,;4.9,20.17,;4.5,18.68,;5.59,17.59,;7.08,17.99,;7.48,19.48,;6.39,20.57,)| Show InChI InChI=1S/C26H34N6O2/c1-30(2)26(20-9-4-3-5-10-20)13-11-25(12-14-26)18-31(21-15-28-23(22(27)33)29-16-21)24(34)32(25)17-19-7-6-8-19/h3-5,9-10,15-16,19H,6-8,11-14,17-18H2,1-2H3,(H2,27,33)/t25-,26+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.700 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Grünenthal GmbH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 mM M... |
US Patent US10807988 (2020)
BindingDB Entry DOI: 10.7270/Q25Q5060 |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469419
(US10807988, Example SC_3063 | cis-5-[1-[(1-Cyano-c...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(C(=O)N2CC2(CCC2)C#N)c2ccc(nc2)C#N)CC1)c1ccccc1 |r,wU:6.11,3.2,(4.15,11.34,;4.92,10,;6.46,10,;4.15,8.67,;3.38,7.34,;1.84,7.34,;1.07,8.67,;.17,9.92,;-1.3,9.44,;-1.3,7.9,;-2.54,6.99,;.17,7.42,;.64,5.96,;-.39,4.81,;-1.93,4.81,;-1.93,3.27,;-.39,3.27,;.95,4.04,;2.28,3.27,;-2.39,10.53,;-1.99,12.02,;-3.08,13.1,;-4.56,12.71,;-4.96,11.22,;-3.87,10.13,;-5.9,13.48,;-7.23,14.25,;1.84,10,;3.38,10,;4.92,7.34,;4.15,6,;4.92,4.67,;6.46,4.67,;7.23,6,;6.46,7.34,)| Show InChI InChI=1S/C28H32N6O/c1-32(2)28(22-7-4-3-5-8-22)15-13-27(14-16-28)21-33(24-10-9-23(17-29)31-18-24)25(35)34(27)20-26(19-30)11-6-12-26/h3-5,7-10,18H,6,11-16,20-21H2,1-2H3/t27-,28+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.700 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Grünenthal GmbH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 mM M... |
US Patent US10807988 (2020)
BindingDB Entry DOI: 10.7270/Q25Q5060 |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469858
(CIS-N-(4-Cyano-5-methylsulfanyl-1H-pyrazol-3-yl)-2...)Show SMILES CSc1[nH]nc(NC(=O)CN2C[C@]3(CC[C@@](CC3)(N(C)C)c3ccccc3)N(CC3CCC3)C2=O)c1C#N |r,wU:15.18,12.28,(19.85,-25.97,;18.31,-25.97,;17.54,-27.3,;18.17,-28.71,;17.02,-29.74,;15.69,-28.97,;14.2,-29.37,;13.11,-28.28,;13.51,-26.79,;11.62,-28.68,;10.54,-27.59,;9.07,-28.06,;8.17,-26.82,;7.4,-25.48,;5.86,-25.48,;5.09,-26.82,;5.86,-28.15,;7.4,-28.15,;4,-27.91,;2.51,-27.51,;4.39,-29.39,;4,-25.73,;4.39,-24.24,;3.31,-23.15,;1.82,-23.55,;1.42,-25.04,;2.51,-26.13,;9.07,-25.57,;8.67,-24.08,;9.76,-22.99,;11.3,-22.99,;11.3,-21.45,;9.76,-21.45,;10.54,-26.05,;11.62,-24.96,;16.01,-27.46,;15.24,-26.13,;13.7,-26.13,)| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.800 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRÜNENTHAL GMBH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl, 10 mM M... |
US Patent US10807989 (2020)
BindingDB Entry DOI: 10.7270/Q2222XTM |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469365
(US10807988, Example SC_3014 | cis-2-[1-(Cyclobutyl...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(C(=O)N2CC2CCC2)c2ncc(cn2)C#N)CC1)c1ccccc1 |r,wU:6.11,3.2,(4.52,9.91,;5.29,8.58,;6.83,8.58,;4.52,7.24,;3.75,5.91,;2.21,5.91,;1.44,7.24,;.53,8.49,;-.93,8.01,;-.93,6.47,;-2.18,5.57,;.53,6,;1.01,4.53,;-.02,3.39,;-1.56,3.39,;-1.56,1.85,;-.02,1.85,;-2.26,8.78,;-2.26,10.32,;-3.6,11.09,;-4.93,10.32,;-4.93,8.78,;-3.6,8.01,;-6.27,11.09,;-7.6,11.86,;2.21,8.58,;3.75,8.58,;5.29,5.91,;4.52,4.58,;5.29,3.24,;6.83,3.24,;7.6,4.58,;6.83,5.91,)| Show InChI InChI=1S/C26H32N6O/c1-30(2)26(22-9-4-3-5-10-22)13-11-25(12-14-26)19-31(23-28-16-21(15-27)17-29-23)24(33)32(25)18-20-7-6-8-20/h3-5,9-10,16-17,20H,6-8,11-14,18-19H2,1-2H3/t25-,26+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.800 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Grünenthal GmbH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 mM M... |
US Patent US10807988 (2020)
BindingDB Entry DOI: 10.7270/Q25Q5060 |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469884
(CIS-1-(Cyclobutyl-methyl)-8-dimethylamino-3-[2-(1,...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(CC(=O)N3CCS(=O)(=O)CC3)C(=O)N2CC2CCC2)CC1)c1ccccc1 |r,wU:6.23,3.2,(15.69,4.95,;16.08,3.47,;17.57,3.07,;15,2.38,;14.23,1.04,;12.69,1.04,;11.92,2.38,;11.01,3.62,;9.55,3.15,;8.21,3.92,;6.88,3.15,;6.88,1.61,;5.54,3.92,;5.54,5.46,;4.21,6.23,;2.88,5.46,;1.54,4.69,;2.48,6.95,;2.88,3.92,;4.21,3.15,;9.55,1.61,;8.21,.84,;11.01,1.13,;11.41,-.36,;10.32,-1.44,;8.78,-1.44,;8.78,-2.98,;10.32,-2.98,;12.69,3.71,;14.23,3.71,;16.33,1.61,;16.33,.07,;17.66,-.7,;19,.07,;19,1.61,;17.66,2.38,)| Show InChI InChI=1S/C27H40N4O4S/c1-28(2)27(23-9-4-3-5-10-23)13-11-26(12-14-27)21-30(25(33)31(26)19-22-7-6-8-22)20-24(32)29-15-17-36(34,35)18-16-29/h3-5,9-10,22H,6-8,11-21H2,1-2H3/t26-,27+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.800 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRÜNENTHAL GMBH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl, 10 mM M... |
US Patent US10807989 (2020)
BindingDB Entry DOI: 10.7270/Q2222XTM |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469822
(CIS-2-[1-(Cyclobutyl-methyl)-8-dimethylamino-2-oxo...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(CC(=O)Nc3ccc(cn3)S(C)(=O)=O)C(=O)N2CC2CCC2)CC1)c1ccccc1 |r,wU:6.26,3.2,(-2.76,30.22,;-4.25,30.62,;-4.65,32.11,;-5.34,29.53,;-6.11,28.2,;-7.65,28.2,;-8.42,29.53,;-9.32,30.78,;-10.79,30.3,;-11.88,31.39,;-13.36,30.99,;-13.76,29.5,;-14.45,32.08,;-15.94,31.68,;-16.34,30.2,;-17.83,29.8,;-18.92,30.89,;-18.52,32.37,;-17.03,32.77,;-20.4,30.49,;-20,29,;-21.89,30.09,;-20.8,31.97,;-10.79,28.76,;-12.12,27.99,;-9.32,28.29,;-8.92,26.8,;-10.01,25.71,;-11.55,25.71,;-11.55,24.17,;-10.01,24.17,;-7.65,30.87,;-6.11,30.87,;-4.25,28.44,;-4.65,26.96,;-3.56,25.87,;-2.07,26.27,;-1.67,27.75,;-2.76,28.84,)| Show InChI InChI=1S/C29H39N5O4S/c1-32(2)29(23-10-5-4-6-11-23)16-14-28(15-17-29)21-33(27(36)34(28)19-22-8-7-9-22)20-26(35)31-25-13-12-24(18-30-25)39(3,37)38/h4-6,10-13,18,22H,7-9,14-17,19-21H2,1-3H3,(H,30,31,35)/t28-,29+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.800 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRÜNENTHAL GMBH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl, 10 mM M... |
US Patent US10807989 (2020)
BindingDB Entry DOI: 10.7270/Q2222XTM |
More data for this
Ligand-Target Pair | |
Mu-type opioid receptor
(Homo sapiens (Human)) | BDBM472009
(CIS-1-(Cyclobutyl-methyl)-8-dimethylamino-8-phenyl...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(Cc3cccnc3)C(=O)N2CC2CCC2)CC1)c1ccccc1 |r,wU:6.19,3.2,(-9.05,-2.42,;-8.28,-3.76,;-6.74,-3.76,;-9.05,-5.09,;-9.82,-6.42,;-11.36,-6.42,;-12.13,-5.09,;-13.04,-3.84,;-14.5,-4.32,;-15.84,-3.55,;-17.17,-4.32,;-17.17,-5.86,;-18.51,-6.63,;-19.84,-5.86,;-19.84,-4.32,;-18.51,-3.55,;-14.5,-5.86,;-15.84,-6.63,;-13.04,-6.34,;-12.27,-7.67,;-13.36,-8.76,;-14.9,-8.76,;-14.9,-10.3,;-13.36,-10.3,;-11.36,-3.76,;-9.82,-3.76,;-8.28,-6.42,;-9.05,-7.76,;-8.28,-9.09,;-6.74,-9.09,;-5.97,-7.76,;-6.74,-6.42,)| Show InChI InChI=1S/C27H36N4O/c1-29(2)27(24-11-4-3-5-12-24)15-13-26(14-16-27)21-30(19-23-10-7-17-28-18-23)25(32)31(26)20-22-8-6-9-22/h3-5,7,10-12,17-18,22H,6,8-9,13-16,19-21H2,1-2H3/t26-,27+ | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.800 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRUENENTHAL GMBH
US Patent
| Assay Description
Mu-Opioid Peptide (hMOP): The hMOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buff... |
US Patent US10829480 (2020)
BindingDB Entry DOI: 10.7270/Q2SB48SB |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469848
(CIS-6-[[2-[1-(Cyclobutyl-methyl)-8-dimethylamino-2...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(CC(=O)Nc3cccc(n3)C(N)=O)C(=O)N2CC2CCC2)CC1)c1ccccc1 |r,wU:6.25,3.2,(20.47,-25.11,;18.98,-24.71,;18.58,-23.22,;17.89,-25.8,;17.12,-27.13,;15.58,-27.13,;14.81,-25.8,;13.9,-24.55,;12.44,-25.03,;11.11,-24.26,;9.77,-25.03,;9.77,-26.57,;8.44,-24.26,;7.1,-25.03,;7.1,-26.57,;5.77,-27.34,;4.44,-26.57,;4.44,-25.03,;5.77,-24.26,;3.1,-24.26,;1.77,-25.03,;3.1,-22.72,;12.44,-26.57,;11.11,-27.34,;13.9,-27.05,;14.3,-28.53,;13.21,-29.62,;11.67,-29.62,;11.67,-31.16,;13.21,-31.16,;15.58,-24.47,;17.12,-24.47,;19.22,-26.57,;19.22,-28.11,;20.56,-28.88,;21.89,-28.11,;21.89,-26.57,;20.56,-25.8,)| Show InChI InChI=1S/C29H38N6O3/c1-33(2)29(22-10-4-3-5-11-22)16-14-28(15-17-29)20-34(27(38)35(28)18-21-8-6-9-21)19-25(36)32-24-13-7-12-23(31-24)26(30)37/h3-5,7,10-13,21H,6,8-9,14-20H2,1-2H3,(H2,30,37)(H,31,32,36)/t28-,29+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.800 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRÜNENTHAL GMBH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl, 10 mM M... |
US Patent US10807989 (2020)
BindingDB Entry DOI: 10.7270/Q2222XTM |
More data for this
Ligand-Target Pair | |
Mu-type opioid receptor
(Homo sapiens (Human)) | BDBM472098
(CIS-1-(Cyclobutyl-methyl)-8-dimethylamino-3-[(3-me...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(Cc3cccc(c3)S(C)(=O)=O)C(=O)N2CC2CCC2)CC1)c1ccccc1 |r,wU:6.23,3.2,(16.32,28.25,;17.09,26.91,;18.63,26.91,;16.32,25.58,;15.55,24.25,;14.01,24.25,;13.24,25.58,;12.34,26.82,;10.87,26.35,;9.54,27.12,;8.2,26.35,;8.2,24.81,;6.87,24.04,;5.54,24.81,;5.54,26.35,;6.87,27.12,;4.2,27.12,;2.87,26.35,;2.87,27.89,;5.54,27.89,;10.87,24.81,;9.54,24.04,;12.34,24.33,;12.73,22.85,;11.65,21.76,;10.11,21.76,;10.11,20.22,;11.65,20.22,;14.01,26.91,;15.55,26.91,;17.09,24.25,;16.32,22.91,;17.09,21.58,;18.63,21.58,;19.4,22.91,;18.63,24.25,)| Show InChI InChI=1S/C29H39N3O3S/c1-30(2)29(25-12-5-4-6-13-25)17-15-28(16-18-29)22-31(27(33)32(28)21-23-9-7-10-23)20-24-11-8-14-26(19-24)36(3,34)35/h4-6,8,11-14,19,23H,7,9-10,15-18,20-22H2,1-3H3/t28-,29+ | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.800 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRUENENTHAL GMBH
US Patent
| Assay Description
Mu-Opioid Peptide (hMOP): The hMOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buff... |
US Patent US10829480 (2020)
BindingDB Entry DOI: 10.7270/Q2SB48SB |
More data for this
Ligand-Target Pair | |
Mu-type opioid receptor
(Homo sapiens (Human)) | BDBM471982
(CIS-2-[[1-(Cyclobutyl-methyl)-8-dimethylamino-2-ox...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(Cc3ccccc3C(N)=O)C(=O)N2CC2CCC2)CC1)c1ccccc1 |r,wU:6.22,3.2,(13.3,8.59,;13.7,7.1,;15.19,6.7,;12.61,6.01,;11.84,4.68,;10.3,4.68,;9.53,6.01,;8.63,7.26,;7.16,6.78,;5.83,7.55,;4.5,6.78,;4.5,5.24,;3.16,4.47,;1.83,5.24,;1.83,6.78,;3.16,7.55,;3.16,9.09,;4.5,9.86,;1.83,9.86,;7.16,5.24,;5.83,4.47,;8.63,4.76,;9.03,3.28,;7.94,2.19,;6.4,2.19,;6.4,.65,;7.94,.65,;10.3,7.34,;11.84,7.34,;13.7,4.92,;13.7,3.38,;15.03,2.61,;16.37,3.38,;16.37,4.92,;15.04,5.69,)| Show InChI InChI=1S/C29H38N4O2/c1-31(2)29(24-12-4-3-5-13-24)17-15-28(16-18-29)21-32(27(35)33(28)19-22-9-8-10-22)20-23-11-6-7-14-25(23)26(30)34/h3-7,11-14,22H,8-10,15-21H2,1-2H3,(H2,30,34)/t28-,29+ | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.800 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRUENENTHAL GMBH
US Patent
| Assay Description
Mu-Opioid Peptide (hMOP): The hMOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buff... |
US Patent US10829480 (2020)
BindingDB Entry DOI: 10.7270/Q2SB48SB |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469908
(CIS-2-[1-(Cyclobutyl-methyl)-8-dimethylamino-2-oxo...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(CC(=O)Nc3cccc(n3)S(C)(=O)=O)C(=O)N2CC2CCC2)CC1)c1ccccc1 |r,wU:3.2,6.26,(16.98,31.77,;17.75,30.44,;19.29,30.44,;16.98,29.1,;16.21,27.77,;14.67,27.77,;13.9,29.1,;13,30.35,;11.53,29.87,;10.2,30.64,;8.87,29.87,;8.87,28.33,;7.53,30.64,;6.2,29.87,;6.2,28.33,;4.87,27.56,;3.53,28.33,;3.53,29.87,;4.87,30.64,;2.2,30.64,;.87,29.87,;1.11,31.73,;3.29,31.73,;11.53,28.33,;10.2,27.56,;13,27.86,;13.4,26.37,;12.31,25.28,;10.77,25.28,;10.77,23.74,;12.31,23.74,;14.67,30.44,;16.21,30.44,;17.75,27.77,;16.98,26.44,;17.75,25.1,;19.29,25.1,;20.06,26.44,;19.29,27.77,)| Show InChI InChI=1S/C29H39N5O4S/c1-32(2)29(23-11-5-4-6-12-23)17-15-28(16-18-29)21-33(27(36)34(28)19-22-9-7-10-22)20-25(35)30-24-13-8-14-26(31-24)39(3,37)38/h4-6,8,11-14,22H,7,9-10,15-21H2,1-3H3,(H,30,31,35)/t28-,29+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.900 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRÜNENTHAL GMBH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl, 10 mM M... |
US Patent US10807989 (2020)
BindingDB Entry DOI: 10.7270/Q2222XTM |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469398
(US10807988, Example SC_3041 | cis-5-[1-[(1-Cyano-c...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(C(=O)N2CC2(CCC2)C#N)c2cnc(nc2)C#N)CC1)c1ccccc1 |r,wU:6.11,3.2,(3.2,23.24,;3.97,21.91,;5.51,21.91,;3.2,20.58,;2.43,19.24,;.89,19.24,;.12,20.58,;-.79,21.82,;-2.25,21.35,;-2.25,19.81,;-3.5,18.9,;-.79,19.33,;-.31,17.87,;-1.34,16.72,;-2.88,16.64,;-2.8,15.1,;-1.26,15.18,;.14,16.32,;1.63,15.92,;-3.5,22.25,;-3.34,23.78,;-4.58,24.69,;-5.99,24.06,;-6.15,22.53,;-4.91,21.62,;-7.24,24.97,;-8.33,26.06,;.89,21.91,;2.43,21.91,;3.97,19.24,;3.2,17.91,;3.97,16.57,;5.51,16.57,;6.28,17.91,;5.51,19.24,)| Show InChI InChI=1S/C27H31N7O/c1-32(2)27(21-7-4-3-5-8-21)13-11-26(12-14-27)20-33(22-16-30-23(15-28)31-17-22)24(35)34(26)19-25(18-29)9-6-10-25/h3-5,7-8,16-17H,6,9-14,19-20H2,1-2H3/t26-,27+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.900 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Grünenthal GmbH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 mM M... |
US Patent US10807988 (2020)
BindingDB Entry DOI: 10.7270/Q25Q5060 |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469922
(CIS-2-[1-(Cyclobutyl-methyl)-8-dimethylamino-2-oxo...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(CC(=O)NCCS(C)(=O)=O)C(=O)N2CC2CCC2)CC1)c1ccccc1 |r,wU:3.2,6.21,(17.11,-6.79,;17.5,-8.28,;18.99,-8.68,;16.42,-9.37,;15.65,-10.7,;14.11,-10.7,;13.34,-9.37,;12.43,-8.12,;10.97,-8.6,;9.63,-7.83,;8.3,-8.6,;8.3,-10.14,;6.96,-7.83,;5.63,-8.6,;4.3,-7.83,;2.96,-8.6,;1.63,-7.83,;1.87,-9.69,;4.05,-9.69,;10.97,-10.14,;9.63,-10.91,;12.43,-10.62,;12.83,-12.1,;11.74,-13.19,;10.2,-13.19,;10.2,-14.73,;11.74,-14.73,;14.11,-8.04,;15.65,-8.04,;17.75,-10.14,;17.75,-11.68,;19.08,-12.45,;20.42,-11.68,;20.42,-10.14,;19.08,-9.37,)| Show InChI InChI=1S/C26H40N4O4S/c1-28(2)26(22-10-5-4-6-11-22)14-12-25(13-15-26)20-29(19-23(31)27-16-17-35(3,33)34)24(32)30(25)18-21-8-7-9-21/h4-6,10-11,21H,7-9,12-20H2,1-3H3,(H,27,31)/t25-,26+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 0.900 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRÜNENTHAL GMBH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl, 10 mM M... |
US Patent US10807989 (2020)
BindingDB Entry DOI: 10.7270/Q2222XTM |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469458
(US10807988, Example SC_3100 | cis-8-Dimethylamino-...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(C(=O)N2CC2(O)CCC2)c2cnc(nc2)N2CCNCC2)CC1)c1ccccc1 |r,wU:6.11,3.2,(5.13,-7.04,;5.9,-8.37,;7.44,-8.37,;5.13,-9.7,;4.36,-11.04,;2.82,-11.04,;2.05,-9.7,;1.15,-8.46,;-.32,-8.93,;-.32,-10.47,;-1.57,-11.38,;1.15,-10.95,;1.62,-12.41,;.59,-13.56,;2.08,-13.96,;-.95,-13.56,;-.95,-15.1,;.59,-15.1,;-1.5,-7.94,;-2.94,-8.46,;-4.12,-7.47,;-3.85,-5.95,;-2.4,-5.43,;-1.22,-6.42,;-5.03,-4.96,;-4.75,-3.44,;-5.93,-2.45,;-7.38,-2.97,;-7.65,-4.49,;-6.47,-5.48,;2.82,-8.37,;4.36,-8.37,;5.9,-11.04,;5.13,-12.37,;5.9,-13.7,;7.44,-13.7,;8.21,-12.37,;7.44,-11.04,)| Show InChI InChI=1S/C29H41N7O2/c1-33(2)29(23-7-4-3-5-8-23)13-11-27(12-14-29)21-35(26(37)36(27)22-28(38)9-6-10-28)24-19-31-25(32-20-24)34-17-15-30-16-18-34/h3-5,7-8,19-20,30,38H,6,9-18,21-22H2,1-2H3/t27-,29+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Grünenthal GmbH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 mM M... |
US Patent US10807988 (2020)
BindingDB Entry DOI: 10.7270/Q25Q5060 |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM470043
(CIS-8-Dimethylamino-1-[(1-hydroxy-cyclobutyl)-meth...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(CC(=O)N3CCC(CC3)S(C)(=O)=O)C(=O)N2CC2(O)CCC2)CC1)c1ccccc1 |r,wU:6.25,3.2,(-5.65,-21.92,;-4.88,-23.25,;-3.34,-23.25,;-5.65,-24.59,;-6.42,-25.92,;-7.96,-25.92,;-8.73,-24.59,;-9.63,-23.34,;-11.1,-23.82,;-12.43,-23.05,;-13.76,-23.82,;-13.76,-25.36,;-15.1,-23.05,;-15.1,-21.51,;-16.43,-20.74,;-17.76,-21.51,;-17.76,-23.05,;-16.43,-23.82,;-19.1,-20.74,;-20.43,-21.51,;-19.87,-19.4,;-18.33,-19.4,;-11.1,-25.36,;-12.43,-26.13,;-9.63,-25.83,;-8.86,-27.17,;-9.95,-28.26,;-8.62,-29.03,;-11.49,-28.26,;-11.49,-29.8,;-9.95,-29.8,;-7.96,-23.25,;-6.42,-23.25,;-4.88,-25.92,;-5.65,-27.25,;-4.88,-28.59,;-3.34,-28.59,;-2.57,-27.25,;-3.34,-25.92,)| Show InChI InChI=1S/C29H44N4O5S/c1-30(2)29(23-8-5-4-6-9-23)16-14-27(15-17-29)21-32(26(35)33(27)22-28(36)12-7-13-28)20-25(34)31-18-10-24(11-19-31)39(3,37)38/h4-6,8-9,24,36H,7,10-22H2,1-3H3/t27-,29+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRÜNENTHAL GMBH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl, 10 mM M... |
US Patent US10807989 (2020)
BindingDB Entry DOI: 10.7270/Q2222XTM |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469980
(CIS-1-(Cyclobutyl-methyl)-8-dimethylamino-3-[2-(1,...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(CC(=O)N3CCS(=O)(=O)CC3)C(=O)N2CC2CCC2)CC1)c1ccccc1 |r,wU:6.23,3.2,(-7.34,-21.48,;-6.57,-22.81,;-5.03,-22.81,;-7.34,-24.15,;-8.11,-25.48,;-9.65,-25.48,;-10.42,-24.15,;-11.33,-22.9,;-12.79,-23.38,;-13.88,-22.29,;-15.37,-22.69,;-15.77,-24.18,;-16.46,-21.6,;-16.06,-20.11,;-17.15,-19.02,;-18.64,-19.42,;-18.64,-17.88,;-20.12,-19.82,;-19.04,-20.91,;-17.95,-22,;-12.79,-24.92,;-14.13,-25.69,;-11.33,-25.39,;-10.93,-26.88,;-12.02,-27.97,;-13.56,-27.97,;-13.56,-29.51,;-12.02,-29.51,;-9.65,-22.81,;-8.11,-22.81,;-6.57,-25.48,;-7.34,-26.82,;-6.57,-28.15,;-5.03,-28.15,;-4.26,-26.82,;-5.03,-25.48,)| Show InChI InChI=1S/C27H40N4O4S/c1-28(2)27(23-9-4-3-5-10-23)13-11-26(12-14-27)21-30(25(33)31(26)19-22-7-6-8-22)20-24(32)29-15-17-36(34,35)18-16-29/h3-5,9-10,22H,6-8,11-21H2,1-2H3/t26-,27+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRÜNENTHAL GMBH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl, 10 mM M... |
US Patent US10807989 (2020)
BindingDB Entry DOI: 10.7270/Q2222XTM |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469459
(US10807988, Example SC_3101 | cis-1-[(1-Hydroxy-cy...)Show SMILES CN[C@]1(CC[C@]2(CN(C(=O)N2CC2(O)CCC2)c2cnc(nc2)N2CCN(C)CC2)CC1)c1ccccc1 |r,wU:5.10,2.1,(4.75,23.16,;5.52,21.83,;4.75,20.49,;3.98,19.16,;2.44,19.16,;1.67,20.49,;.76,21.74,;-.7,21.26,;-.7,19.72,;-1.95,18.82,;.76,19.25,;1.24,17.78,;.21,16.64,;1.7,16.24,;-1.33,16.64,;-1.33,15.1,;.21,15.1,;-1.88,22.26,;-3.33,21.73,;-4.5,22.73,;-4.23,24.24,;-2.78,24.76,;-1.61,23.77,;-5.41,25.24,;-5.14,26.75,;-6.31,27.74,;-7.76,27.22,;-8.94,28.22,;-8.03,25.71,;-6.86,24.71,;2.44,21.83,;3.98,21.83,;5.52,19.16,;4.75,17.82,;5.52,16.49,;7.06,16.49,;7.83,17.82,;7.06,19.16,)| Show InChI InChI=1S/C29H41N7O2/c1-30-29(23-7-4-3-5-8-23)13-11-27(12-14-29)21-35(26(37)36(27)22-28(38)9-6-10-28)24-19-31-25(32-20-24)34-17-15-33(2)16-18-34/h3-5,7-8,19-20,30,38H,6,9-18,21-22H2,1-2H3/t27-,29+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Grünenthal GmbH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 mM M... |
US Patent US10807988 (2020)
BindingDB Entry DOI: 10.7270/Q25Q5060 |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM470058
(CIS-1-(Cyclopropyl-methyl)-8-dimethylamino-3-[2-(4...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(CC(=O)N3CCC(CC3)S(C)(=O)=O)C(=O)N2CC2CC2)CC1)c1ccccc1 |r,wU:6.25,3.2,(18.09,17.49,;18.09,15.95,;19.43,15.18,;16.76,15.18,;15.99,13.85,;14.45,13.85,;13.68,15.18,;12.77,16.43,;11.31,15.95,;9.97,16.72,;8.64,15.95,;8.64,14.41,;7.31,16.72,;7.31,18.26,;5.97,19.03,;4.64,18.26,;4.64,16.72,;5.97,15.95,;3.31,19.03,;1.97,18.26,;2.54,20.36,;4.08,20.36,;11.31,14.41,;9.97,13.64,;12.77,13.93,;13.54,12.6,;12.45,11.51,;10.97,11.11,;12.06,10.02,;14.45,16.51,;15.99,16.51,;17.53,13.85,;16.76,12.51,;17.53,11.18,;19.07,11.18,;19.84,12.51,;19.07,13.85,)| Show InChI InChI=1S/C28H42N4O4S/c1-29(2)28(23-7-5-4-6-8-23)15-13-27(14-16-28)21-31(26(34)32(27)19-22-9-10-22)20-25(33)30-17-11-24(12-18-30)37(3,35)36/h4-8,22,24H,9-21H2,1-3H3/t27-,28+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRÜNENTHAL GMBH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl, 10 mM M... |
US Patent US10807989 (2020)
BindingDB Entry DOI: 10.7270/Q2222XTM |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM470044
(CIS-2-[1-(Cyclobutyl-methyl)-8-dimethylamino-8-(3-...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(CC(=O)NCCO)C(=O)N2CC2CCC2)CC1)c1cccc(F)c1 |r,wU:6.18,3.2,(13.32,-21.31,;14.09,-22.64,;15.63,-22.64,;13.32,-23.98,;12.55,-25.31,;11.01,-25.31,;10.24,-23.98,;9.34,-22.73,;7.87,-23.21,;6.78,-22.12,;5.29,-22.52,;4.9,-24,;4.2,-21.43,;2.72,-21.83,;1.63,-20.74,;2.4,-19.4,;7.87,-24.75,;6.54,-25.52,;9.34,-25.22,;9.73,-26.71,;8.64,-27.8,;7.1,-27.8,;7.1,-29.34,;8.64,-29.34,;11.01,-22.64,;12.55,-22.64,;14.09,-25.31,;13.32,-26.64,;14.09,-27.98,;15.63,-27.98,;16.4,-26.64,;17.94,-26.64,;15.63,-25.31,)| Show InChI InChI=1S/C25H37FN4O3/c1-28(2)25(20-7-4-8-21(26)15-20)11-9-24(10-12-25)18-29(17-22(32)27-13-14-31)23(33)30(24)16-19-5-3-6-19/h4,7-8,15,19,31H,3,5-6,9-14,16-18H2,1-2H3,(H,27,32)/t24-,25+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRÜNENTHAL GMBH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl, 10 mM M... |
US Patent US10807989 (2020)
BindingDB Entry DOI: 10.7270/Q2222XTM |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469432
(US10807988, Example SC_3073 | cis-1-(Cyclobutyl-me...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(C(=O)N2CC2CCC2)c2cnc(nc2)C(F)(F)F)CC1)c1ccccc1 |r,wU:6.11,3.2,(2.77,-19.58,;3.54,-20.91,;5.08,-20.91,;2.77,-22.25,;2,-23.58,;.46,-23.58,;-.31,-22.25,;-1.22,-21,;-2.68,-21.48,;-2.68,-23.02,;-3.93,-23.92,;-1.22,-23.49,;-.74,-24.96,;-1.77,-26.1,;-3.31,-26.1,;-3.31,-27.64,;-1.77,-27.64,;-3.77,-20.39,;-3.37,-18.9,;-4.46,-17.81,;-5.95,-18.21,;-6.35,-19.7,;-5.26,-20.78,;-7.04,-17.12,;-8.12,-16.03,;-5.95,-16.03,;-8.12,-18.21,;.46,-20.91,;2,-20.91,;3.54,-23.58,;2.77,-24.91,;3.54,-26.25,;5.08,-26.25,;5.85,-24.91,;5.08,-23.58,)| Show InChI InChI=1S/C26H32F3N5O/c1-32(2)25(20-9-4-3-5-10-20)13-11-24(12-14-25)18-33(23(35)34(24)17-19-7-6-8-19)21-15-30-22(31-16-21)26(27,28)29/h3-5,9-10,15-16,19H,6-8,11-14,17-18H2,1-2H3/t24-,25+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Grünenthal GmbH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 mM M... |
US Patent US10807988 (2020)
BindingDB Entry DOI: 10.7270/Q25Q5060 |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469820
(CIS-2-[1-(Cyclobutyl-methyl)-8-dimethylamino-2-oxo...)Show SMILES COc1cnccc1NC(=O)CN1C[C@]2(CC[C@@](CC2)(N(C)C)c2ccccc2)N(CC2CCC2)C1=O |r,wU:14.31,17.21,(-16.78,-14.08,;-18.26,-14.48,;-18.66,-15.97,;-20.15,-16.37,;-20.55,-17.86,;-19.46,-18.94,;-17.97,-18.55,;-17.57,-17.06,;-16.09,-16.66,;-15,-17.75,;-15.4,-19.24,;-13.51,-17.35,;-12.42,-18.44,;-10.96,-17.96,;-10.05,-19.21,;-9.28,-20.54,;-7.74,-20.54,;-6.97,-19.21,;-7.74,-17.88,;-9.28,-17.88,;-5.88,-18.12,;-4.39,-18.52,;-6.28,-16.63,;-5.88,-20.3,;-6.28,-21.79,;-5.19,-22.87,;-3.7,-22.48,;-3.3,-20.99,;-4.39,-19.9,;-10.96,-20.45,;-10.56,-21.94,;-11.65,-23.03,;-13.19,-23.03,;-13.19,-24.57,;-11.65,-24.57,;-12.42,-19.98,;-13.75,-20.75,)| Show InChI InChI=1S/C29H39N5O3/c1-32(2)29(23-10-5-4-6-11-23)15-13-28(14-16-29)21-33(27(36)34(28)19-22-8-7-9-22)20-26(35)31-24-12-17-30-18-25(24)37-3/h4-6,10-12,17-18,22H,7-9,13-16,19-21H2,1-3H3,(H,30,31,35)/t28-,29+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRÜNENTHAL GMBH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl, 10 mM M... |
US Patent US10807989 (2020)
BindingDB Entry DOI: 10.7270/Q2222XTM |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469872
(CIS-2-[1-(Cyclobutyl-methyl)-8-dimethylamino-2-oxo...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(CC(=O)NCc3cccc(C)n3)C(=O)N2CC2CCC2)CC1)c1ccccc1 |r,wU:6.24,3.2,(15.44,16.16,;16.53,15.08,;18.02,15.47,;16.13,13.59,;16.13,12.05,;14.8,11.28,;13.46,12.05,;12.17,12.89,;10.98,11.92,;9.49,12.32,;8.4,11.23,;8.8,9.74,;6.91,11.63,;5.82,10.54,;4.34,10.93,;3.94,12.42,;2.45,12.82,;1.36,11.73,;1.76,10.24,;.67,9.16,;3.25,9.85,;11.53,10.48,;10.76,9.15,;13.07,10.56,;14.16,9.47,;13.76,7.98,;12.42,7.21,;13.19,5.88,;14.53,6.65,;13.46,13.59,;14.8,14.36,;17.62,13.19,;18.02,11.7,;19.51,11.3,;20.59,12.39,;20.2,13.88,;18.71,14.28,)| Show InChI InChI=1S/C30H41N5O2/c1-23-9-7-14-26(32-23)19-31-27(36)21-34-22-29(35(28(34)37)20-24-10-8-11-24)15-17-30(18-16-29,33(2)3)25-12-5-4-6-13-25/h4-7,9,12-14,24H,8,10-11,15-22H2,1-3H3,(H,31,36)/t29-,30+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRÜNENTHAL GMBH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl, 10 mM M... |
US Patent US10807989 (2020)
BindingDB Entry DOI: 10.7270/Q2222XTM |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469764
(US10807988, Example SC_3401 | cis-1-(Cyclobutyl-me...)Show SMILES CN[C@]1(CC[C@]2(CN(C(=O)N2CC2CCC2)c2cnc(nc2)C(F)(F)F)CC1)c1cccc(F)c1 |r,wU:5.10,2.1,(12.36,-8.78,;13.13,-10.11,;12.36,-11.45,;11.59,-12.78,;10.05,-12.78,;9.28,-11.45,;8.37,-10.2,;6.91,-10.68,;6.91,-12.22,;5.58,-12.99,;8.37,-12.69,;9.14,-14.03,;8.37,-15.36,;6.83,-15.36,;6.83,-16.9,;8.37,-16.9,;5.82,-9.59,;6.22,-8.1,;5.13,-7.01,;3.64,-7.41,;3.24,-8.9,;4.33,-9.99,;2.55,-6.32,;1.07,-6.72,;2.95,-4.83,;1.46,-5.23,;10.05,-10.11,;11.59,-10.11,;13.13,-12.78,;12.36,-14.11,;13.13,-15.45,;14.67,-15.45,;15.44,-14.11,;16.98,-14.11,;14.67,-12.78,)| Show InChI InChI=1S/C25H29F4N5O/c1-30-24(18-6-3-7-19(26)12-18)10-8-23(9-11-24)16-33(22(35)34(23)15-17-4-2-5-17)20-13-31-21(32-14-20)25(27,28)29/h3,6-7,12-14,17,30H,2,4-5,8-11,15-16H2,1H3/t23-,24+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Grünenthal GmbH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 mM M... |
US Patent US10807988 (2020)
BindingDB Entry DOI: 10.7270/Q25Q5060 |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469854
(CIS-2-[1-(Cyclobutyl-methyl)-8-dimethylamino-2-oxo...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(CC(=O)Nc3nccs3)C(=O)N2CC2CCC2)CC1)c1ccccc1 |r,wU:6.21,3.2,(13.06,5.68,;14.14,4.59,;15.63,4.99,;13.75,3.1,;13.75,1.56,;12.41,.79,;11.08,1.56,;9.79,2.4,;8.59,1.43,;7.1,1.83,;6.01,.74,;6.41,-.74,;4.53,1.14,;3.44,.05,;1.9,.05,;1.42,-1.41,;2.67,-2.32,;3.91,-1.41,;9.14,-0,;8.37,-1.34,;10.68,.08,;11.77,-1.01,;11.37,-2.5,;10.04,-3.27,;10.81,-4.6,;12.14,-3.83,;11.08,3.1,;12.41,3.87,;15.23,2.7,;15.63,1.22,;17.12,.82,;18.21,1.91,;17.81,3.4,;16.32,3.79,)| Show InChI InChI=1S/C26H35N5O2S/c1-29(2)26(21-9-4-3-5-10-21)13-11-25(12-14-26)19-30(18-22(32)28-23-27-15-16-34-23)24(33)31(25)17-20-7-6-8-20/h3-5,9-10,15-16,20H,6-8,11-14,17-19H2,1-2H3,(H,27,28,32)/t25-,26+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRÜNENTHAL GMBH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl, 10 mM M... |
US Patent US10807989 (2020)
BindingDB Entry DOI: 10.7270/Q2222XTM |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469395
(US10807988, Example SC_3038 | cis-1-(Cyclobutyl-me...)Show SMILES CN[C@]1(CC[C@]2(CN(C(=O)N2CC2CCC2)c2cnc(nc2)C(F)(F)F)CC1)c1ccccc1 |r,wU:5.10,2.1,(4.02,11.95,;4.42,10.46,;3.33,9.37,;2.56,8.04,;1.02,8.04,;.25,9.37,;-.66,10.62,;-2.12,10.14,;-2.12,8.6,;-3.37,7.7,;-.66,8.13,;-.18,6.66,;-1.21,5.52,;-2.75,5.52,;-2.75,3.98,;-1.21,3.98,;-3.45,10.91,;-3.45,12.45,;-4.79,13.22,;-6.12,12.45,;-6.12,10.91,;-4.79,10.14,;-7.45,13.22,;-8.79,13.99,;-6.68,14.56,;-8.22,11.89,;1.02,10.71,;2.56,10.71,;4.66,8.6,;4.66,7.06,;6,6.29,;7.33,7.06,;7.33,8.6,;6,9.37,)| Show InChI InChI=1S/C25H30F3N5O/c1-29-24(19-8-3-2-4-9-19)12-10-23(11-13-24)17-32(22(34)33(23)16-18-6-5-7-18)20-14-30-21(31-15-20)25(26,27)28/h2-4,8-9,14-15,18,29H,5-7,10-13,16-17H2,1H3/t23-,24+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Grünenthal GmbH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 mM M... |
US Patent US10807988 (2020)
BindingDB Entry DOI: 10.7270/Q25Q5060 |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469378
(US10807988, Example SC_3024 | cis-5-[8-Dimethylami...)Show SMILES CC(C)CN1C(=O)N(C[C@]11CC[C@@](CC1)(N(C)C)c1ccccc1)c1cnc(nc1)C#N |r,wU:9.9,12.16,(.13,-25.61,;-.34,-24.14,;-1.85,-23.82,;.69,-23,;.21,-21.53,;-1.25,-21.06,;-2.5,-21.96,;-1.25,-19.52,;.21,-19.04,;1.12,-20.29,;1.89,-21.62,;3.43,-21.62,;4.2,-20.29,;3.43,-18.95,;1.89,-18.95,;4.97,-18.95,;4.2,-17.62,;6.51,-18.95,;4.97,-21.62,;4.2,-22.95,;4.97,-24.29,;6.51,-24.29,;7.28,-22.95,;6.51,-21.62,;-2.5,-18.61,;-2.34,-17.08,;-3.58,-16.18,;-4.99,-16.8,;-5.15,-18.33,;-3.91,-19.24,;-6.24,-15.9,;-7.48,-14.99,)| Show InChI InChI=1S/C25H32N6O/c1-19(2)17-31-23(32)30(21-15-27-22(14-26)28-16-21)18-24(31)10-12-25(13-11-24,29(3)4)20-8-6-5-7-9-20/h5-9,15-16,19H,10-13,17-18H2,1-4H3/t24-,25+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Grünenthal GmbH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 mM M... |
US Patent US10807988 (2020)
BindingDB Entry DOI: 10.7270/Q25Q5060 |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469785
(CIS-2-[1-(Cyclobutyl-methyl)-8-dimethylamino-2-oxo...)Show SMILES COc1cccc(NC(=O)CN2C[C@]3(CC[C@@](CC3)(N(C)C)c3ccccc3)N(CC3CCC3)C2=O)n1 |r,wU:13.29,16.19,(.96,9.11,;2.29,9.88,;3.63,9.11,;3.63,7.57,;4.96,6.8,;6.29,7.57,;6.29,9.11,;7.63,9.88,;8.96,9.11,;8.96,7.57,;10.29,9.88,;11.63,9.11,;13.09,9.59,;14,8.34,;14.77,7.01,;16.31,7.01,;17.08,8.34,;16.31,9.67,;14.77,9.67,;18.17,9.43,;17.77,10.92,;19.65,9.03,;18.41,7.57,;18.41,6.03,;19.74,5.26,;21.08,6.03,;21.08,7.57,;19.74,8.34,;13.09,7.09,;13.49,5.61,;12.4,4.52,;10.86,4.52,;10.86,2.98,;12.4,2.98,;11.63,7.57,;10.29,6.8,;4.96,9.88,)| Show InChI InChI=1S/C29H39N5O3/c1-32(2)29(23-11-5-4-6-12-23)17-15-28(16-18-29)21-33(27(36)34(28)19-22-9-7-10-22)20-25(35)30-24-13-8-14-26(31-24)37-3/h4-6,8,11-14,22H,7,9-10,15-21H2,1-3H3,(H,30,31,35)/t28-,29+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRÜNENTHAL GMBH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl, 10 mM M... |
US Patent US10807989 (2020)
BindingDB Entry DOI: 10.7270/Q2222XTM |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469708
(US10807988, Example SC_3344 | cis-8-Dimethylamino-...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(C(=O)N2)c2cnc(nc2)-c2cccc3C(=O)NCc23)CC1)c1ccccc1 |r,wU:6.11,3.2,(-1.54,-1.31,;-3.03,-.91,;-3.43,.58,;-4.12,-2,;-4.89,-3.33,;-6.43,-3.33,;-7.2,-2,;-8.1,-.75,;-9.57,-1.23,;-9.57,-2.77,;-10.9,-3.54,;-8.1,-3.24,;-10.58,-.18,;-10.19,1.31,;-11.27,2.39,;-12.76,2,;-13.16,.51,;-12.07,-.58,;-13.85,3.09,;-13.45,4.57,;-14.54,5.66,;-16.03,5.26,;-16.43,3.78,;-17.8,3.08,;-19.29,3.47,;-17.56,1.56,;-16.04,1.31,;-15.34,2.69,;-6.43,-.66,;-4.89,-.66,;-3.03,-3.09,;-3.43,-4.57,;-2.34,-5.66,;-.85,-5.26,;-.45,-3.78,;-1.54,-2.69,)| Show InChI InChI=1S/C28H30N6O2/c1-33(2)28(19-7-4-3-5-8-19)13-11-27(12-14-28)18-34(26(36)32-27)20-15-29-24(30-16-20)21-9-6-10-22-23(21)17-31-25(22)35/h3-10,15-16H,11-14,17-18H2,1-2H3,(H,31,35)(H,32,36)/t27-,28+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Grünenthal GmbH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 mM M... |
US Patent US10807988 (2020)
BindingDB Entry DOI: 10.7270/Q25Q5060 |
More data for this
Ligand-Target Pair | |
Prepronociceptin
(Human) | BDBM464438
(US10793528, Example SC_5008)Show SMILES COc1ccc(NC(=O)CCN2C[C@]3(CC[C@@](CC3)(N(C)C)c3ccccc3)N(CC3CCC3)C2=O)nc1 |r,wU:16.19,13.29,(-10.66,.4,;-10.03,-1,;-8.5,-1.16,;-7.87,-2.57,;-6.34,-2.73,;-5.43,-1.49,;-3.9,-1.65,;-3,-.4,;-3.62,1.01,;-1.47,-.56,;-.56,.68,;.97,.52,;2,1.67,;3.41,1.04,;4.74,.27,;6.08,1.04,;6.08,2.58,;4.74,3.35,;3.41,2.58,;6.47,4.07,;7.96,4.47,;5.38,5.16,;7.6,2.38,;8.19,.96,;9.72,.76,;10.66,1.98,;10.07,3.4,;8.54,3.6,;3.25,-.49,;4.39,-1.52,;4.07,-3.03,;2.78,-3.87,;3.62,-5.16,;4.91,-4.32,;1.74,-.81,;1.11,-2.22,;-6.06,-.08,;-7.59,.08,)| Show InChI InChI=1S/C30H41N5O3/c1-33(2)30(24-10-5-4-6-11-24)17-15-29(16-18-30)22-34(28(37)35(29)21-23-8-7-9-23)19-14-27(36)32-26-13-12-25(38-3)20-31-26/h4-6,10-13,20,23H,7-9,14-19,21-22H2,1-3H3,(H,31,32,36)/t29-,30+ | UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRÜNENTHAL GMBH
US Patent
| Assay Description
NOP:The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 ... |
US Patent US10793528 (2020)
BindingDB Entry DOI: 10.7270/Q2Q243B2 |
More data for this
Ligand-Target Pair | |
Prepronociceptin
(Human) | BDBM464476
(US10793528, Example SC_5046)Show SMILES CN(C)[C@]1(CC[C@]2(CN(CC(C)(C)C(N)=O)C(=O)N2CC2CCC2)CC1)c1ccccc1 |r,wU:6.18,3.2,(5.9,3.28,;4.37,3.12,;3.47,4.36,;3.75,1.71,;3.12,.3,;1.59,.14,;.68,1.39,;-.35,2.53,;-1.75,1.9,;-3.09,2.67,;-4.42,1.9,;-4.42,.36,;-4.42,3.44,;-5.75,2.67,;-7.09,1.9,;-5.75,4.21,;-1.59,.37,;-2.74,-.66,;-.09,.05,;.54,-1.35,;-.37,-2.6,;-1.89,-2.84,;-1.65,-4.36,;-.12,-4.12,;1.31,2.79,;2.84,2.95,;4.65,.46,;4.03,-.94,;4.93,-2.19,;6.46,-2.03,;7.09,-.62,;6.18,.62,)| Show InChI InChI=1S/C26H40N4O2/c1-24(2,22(27)31)18-29-19-25(30(23(29)32)17-20-9-8-10-20)13-15-26(16-14-25,28(3)4)21-11-6-5-7-12-21/h5-7,11-12,20H,8-10,13-19H2,1-4H3,(H2,27,31)/t25-,26+ | UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRÜNENTHAL GMBH
US Patent
| Assay Description
NOP:The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 ... |
US Patent US10793528 (2020)
BindingDB Entry DOI: 10.7270/Q2Q243B2 |
More data for this
Ligand-Target Pair | |
Prepronociceptin
(Human) | BDBM464494
(US10793528, Example SC_5069)Show SMILES CCN[C@]1(CC[C@]2(CN(CC(C)(C)C(N)=O)C(=O)N2)CC1)c1ccccc1 |r,wU:6.18,3.2,(4.61,4,;3.84,2.67,;4.61,1.33,;3.84,,;3.07,-1.33,;1.53,-1.33,;.76,,;-.15,1.25,;-1.61,.77,;-2.86,1.68,;-4.26,1.05,;-4.43,-.48,;-5.67,.42,;-5.51,1.95,;-6.92,1.33,;-5.35,3.49,;-1.61,-.77,;-2.86,-1.68,;-.15,-1.25,;1.53,1.33,;3.07,1.33,;4.61,-1.33,;3.84,-2.67,;4.61,-4,;6.15,-4,;6.92,-2.67,;6.15,-1.33,)| Show InChI InChI=1S/C21H32N4O2/c1-4-23-21(16-8-6-5-7-9-16)12-10-20(11-13-21)15-25(18(27)24-20)14-19(2,3)17(22)26/h5-9,23H,4,10-15H2,1-3H3,(H2,22,26)(H,24,27)/t20-,21+ | UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRÜNENTHAL GMBH
US Patent
| Assay Description
NOP:The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 ... |
US Patent US10793528 (2020)
BindingDB Entry DOI: 10.7270/Q2Q243B2 |
More data for this
Ligand-Target Pair | |
Mu-type opioid receptor
(Homo sapiens (Human)) | BDBM469461
(US10807988, Example SC_3103 | cis-1-(Cyclobutyl-me...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(C(=O)N2CC2CCC2)c2cnc(cc2C)C(F)(F)F)CC1)c1ccccc1 |r,wU:6.11,3.2,(4.04,-5.47,;4.81,-6.8,;6.35,-6.8,;4.04,-8.13,;3.27,-9.47,;1.73,-9.47,;.96,-8.13,;.06,-6.89,;-1.41,-7.36,;-1.41,-8.9,;-2.65,-9.81,;.06,-9.38,;.53,-10.84,;-.5,-11.99,;-2.04,-11.99,;-2.04,-13.53,;-.5,-13.53,;-2.74,-6.59,;-4.07,-7.36,;-5.41,-6.59,;-5.41,-5.05,;-4.07,-4.28,;-2.74,-5.05,;-1.41,-4.28,;-6.74,-4.28,;-8.07,-3.51,;-5.97,-2.95,;-7.51,-5.62,;1.73,-6.8,;3.27,-6.8,;4.81,-9.47,;4.04,-10.8,;4.81,-12.14,;6.35,-12.14,;7.12,-10.8,;6.35,-9.47,)| Show InChI InChI=1S/C28H35F3N4O/c1-20-16-24(28(29,30)31)32-17-23(20)34-19-26(35(25(34)36)18-21-8-7-9-21)12-14-27(15-13-26,33(2)3)22-10-5-4-6-11-22/h4-6,10-11,16-17,21H,7-9,12-15,18-19H2,1-3H3/t26-,27+ | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Grünenthal GmbH
US Patent
| Assay Description
The hMOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl (pH 7.4)... |
US Patent US10807988 (2020)
BindingDB Entry DOI: 10.7270/Q25Q5060 |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM464637
(CIS-8-Dimethylamino-1,3-bis(2-methylsulfonyl-ethyl...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(CC3CCN(CC3)c3cncnc3)C(=O)N2CC2CC2)CC1)c1ccccc1 |r,wU:6.26,3.2,(7.97,7.93,;6.48,8.33,;6.48,9.87,;5.39,7.24,;4.62,5.91,;3.08,5.91,;2.31,7.24,;1.41,8.49,;-.06,8.01,;-1.39,8.78,;-2.72,8.01,;-4.06,8.78,;-5.39,8.01,;-5.39,6.47,;-4.06,5.7,;-2.72,6.47,;-6.73,5.7,;-8.06,6.47,;-9.39,5.7,;-9.39,4.16,;-8.06,3.39,;-6.73,4.16,;-.06,6.47,;-1.3,5.56,;1.41,5.99,;1.88,4.53,;.85,3.38,;-.61,2.91,;.53,1.88,;3.08,8.57,;4.62,8.57,;6.73,6.47,;6.73,4.93,;8.06,4.16,;9.39,4.93,;9.39,6.47,;8.06,7.24,)| Show InChI InChI=1S/C30H42N6O/c1-33(2)30(26-6-4-3-5-7-26)14-12-29(13-15-30)22-35(28(37)36(29)21-24-8-9-24)20-25-10-16-34(17-11-25)27-18-31-23-32-19-27/h3-7,18-19,23-25H,8-17,20-22H2,1-2H3/t29-,30+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRUENENTHAL GMBH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 mM M... |
US Patent US10793556 (2020)
BindingDB Entry DOI: 10.7270/Q2XK8JMK |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM464643
(CIS-1-(Cyclopropyl-methyl)-8-dimethylamino-3-[2-me...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(CCC3(O)CCS(=O)(=O)CC3)C(=O)N2CC2CCC2)CC1)c1ccccc1 |r,wU:6.23,3.2,(5.31,-14.15,;3.77,-14.15,;3,-12.81,;3,-15.48,;2.23,-16.81,;.69,-16.81,;-.08,-15.48,;-.98,-14.23,;-2.45,-14.71,;-3.78,-13.94,;-5.12,-14.71,;-6.45,-13.94,;-7.78,-14.71,;-5.12,-13.17,;-5.12,-11.63,;-6.45,-10.86,;-7.22,-9.53,;-5.68,-9.53,;-7.78,-11.63,;-7.78,-13.17,;-2.45,-16.25,;-3.69,-17.16,;-.98,-16.73,;-.51,-18.19,;-1.54,-19.33,;-3.08,-19.33,;-3.08,-20.87,;-1.54,-20.87,;.69,-14.15,;2.23,-14.15,;3.77,-16.81,;3,-18.15,;3.77,-19.48,;5.31,-19.48,;6.08,-18.15,;5.31,-16.81,)| Show InChI InChI=1S/C28H43N3O4S/c1-29(2)28(24-9-4-3-5-10-24)13-11-26(12-14-28)22-30(25(32)31(26)21-23-7-6-8-23)18-15-27(33)16-19-36(34,35)20-17-27/h3-5,9-10,23,33H,6-8,11-22H2,1-2H3/t26-,28+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRUENENTHAL GMBH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 mM M... |
US Patent US10793556 (2020)
BindingDB Entry DOI: 10.7270/Q2XK8JMK |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469405
(US10807988, Example SC_3048 | cis-4-[1-(Cyclobuty1...)Show SMILES CN(C)[C@]1(CC[C@]2(CN(C(=O)N2CC2CCC2)c2ccnc(n2)C#N)CC1)c1ccccc1 |r,wU:6.11,3.2,(5.33,-24.84,;3.85,-24.44,;3.45,-22.95,;2.76,-25.53,;1.99,-26.86,;.45,-26.86,;-.32,-25.53,;-1.23,-24.28,;-2.69,-24.76,;-2.69,-26.3,;-3.94,-27.2,;-1.23,-26.78,;-.75,-28.24,;-1.78,-29.38,;-3.32,-29.38,;-3.32,-30.92,;-1.78,-30.92,;-3.78,-23.67,;-5.27,-24.07,;-6.36,-22.98,;-5.96,-21.49,;-4.47,-21.09,;-3.38,-22.18,;-4.07,-19.61,;-3.67,-18.12,;.45,-24.2,;1.99,-24.2,;3.69,-26.75,;3.1,-28.17,;4.04,-29.4,;5.57,-29.2,;6.16,-27.77,;5.22,-26.55,)| Show InChI InChI=1S/C26H32N6O/c1-30(2)26(21-9-4-3-5-10-21)14-12-25(13-15-26)19-31(23-11-16-28-22(17-27)29-23)24(33)32(25)18-20-7-6-8-20/h3-5,9-11,16,20H,6-8,12-15,18-19H2,1-2H3/t25-,26+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Grünenthal GmbH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl. 10 mM M... |
US Patent US10807988 (2020)
BindingDB Entry DOI: 10.7270/Q25Q5060 |
More data for this
Ligand-Target Pair | |
Mu-type opioid receptor
(Homo sapiens (Human)) | BDBM469460
(US10807988, Example SC_3102 | cis-1-[(1-Hydroxy-cy...)Show SMILES CN[C@]1(CC[C@]2(CN(C(=O)N2CC2(O)CCC2)c2cnc(nc2)N2CCNCC2)CC1)c1ccccc1 |r,wU:5.10,2.1,(5.47,7.44,;6.24,6.1,;5.47,4.77,;4.7,3.43,;3.16,3.43,;2.39,4.77,;1.48,6.01,;.02,5.54,;.02,4,;-1.23,3.09,;1.48,3.52,;1.96,2.06,;.93,.91,;2.42,.51,;-.61,.91,;-.61,-.63,;.93,-.63,;-1.16,6.53,;-2.61,6.01,;-3.78,7,;-3.51,8.52,;-2.06,9.04,;-.89,8.05,;-4.69,9.51,;-4.42,11.03,;-5.59,12.02,;-7.04,11.5,;-7.31,9.98,;-6.14,8.99,;3.16,6.1,;4.7,6.1,;6.24,3.43,;5.47,2.1,;6.24,.77,;7.78,.77,;8.55,2.1,;7.78,3.43,)| Show InChI InChI=1S/C28H39N7O2/c1-29-28(22-6-3-2-4-7-22)12-10-26(11-13-28)20-34(25(36)35(26)21-27(37)8-5-9-27)23-18-31-24(32-19-23)33-16-14-30-15-17-33/h2-4,6-7,18-19,29-30,37H,5,8-17,20-21H2,1H3/t26-,28+ | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Grünenthal GmbH
US Patent
| Assay Description
The hMOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl (pH 7.4)... |
US Patent US10807988 (2020)
BindingDB Entry DOI: 10.7270/Q25Q5060 |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM457042
(US10738015, Example SC-6)Show SMILES CN(C)C1(CC2(C1)CN(CC(=O)N1CCS(=O)(=O)CC1)C(=O)N2CC1CCC1)c1ccccc1 |(-3.15,.25,;-1.63,-.03,;-1.59,-1.57,;-.32,.77,;.77,-.32,;1.86,.77,;.77,1.86,;2.76,2.02,;4.23,1.54,;5.47,2.45,;5.31,3.98,;3.91,4.6,;6.56,4.88,;6.4,6.41,;7.64,7.32,;9.05,6.69,;9.73,8.08,;10.58,6.91,;9.21,5.16,;7.97,4.26,;4.23,,;5.47,-.91,;2.76,-.48,;2.29,-1.94,;3.32,-3.09,;4.86,-3.17,;4.78,-4.7,;3.24,-4.62,;-1.63,1.57,;-2.99,.84,;-4.3,1.64,;-4.26,3.18,;-2.9,3.92,;-1.59,3.11,)| Show InChI InChI=1S/C25H36N4O4S/c1-26(2)25(21-9-4-3-5-10-21)17-24(18-25)19-28(23(31)29(24)15-20-7-6-8-20)16-22(30)27-11-13-34(32,33)14-12-27/h3-5,9-10,20H,6-8,11-19H2,1-2H3 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRÜNENTHAL GMBH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl, 10 mM M... |
US Patent US10738015 (2020)
BindingDB Entry DOI: 10.7270/Q2X63R1R |
More data for this
Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM469842
(CIS-2-[1-(Cyclobutyl-methyl)-8-dimethylamino-2-oxo...)Show SMILES COc1ncc(NC(=O)CN2C[C@]3(CC[C@@](CC3)(N(C)C)c3ccccc3)N(CC3CCC3)C2=O)cn1 |r,wU:12.28,15.18,(.82,10.63,;.82,12.17,;2.16,12.94,;3.49,12.17,;4.83,12.94,;4.83,14.48,;6.16,15.25,;7.49,14.48,;7.49,12.94,;8.83,15.25,;10.16,14.48,;11.62,14.96,;12.53,13.71,;13.3,12.38,;14.84,12.38,;15.61,13.71,;14.84,15.05,;13.3,15.05,;16.7,14.8,;18.19,14.4,;16.3,16.29,;16.94,12.94,;16.94,11.4,;18.28,10.63,;19.61,11.4,;19.61,12.94,;18.28,13.71,;11.62,12.47,;12.02,10.98,;10.93,9.89,;9.39,9.89,;9.39,8.35,;10.93,8.35,;10.16,12.94,;8.83,12.17,;3.49,15.25,;2.16,14.48,)| Show InChI InChI=1S/C28H38N6O3/c1-32(2)28(22-10-5-4-6-11-22)14-12-27(13-15-28)20-33(26(36)34(27)18-21-8-7-9-21)19-24(35)31-23-16-29-25(37-3)30-17-23/h4-6,10-11,16-17,21H,7-9,12-15,18-20H2,1-3H3,(H,31,35)/t27-,28+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GRÜNENTHAL GMBH
US Patent
| Assay Description
The hNOP receptor binding assay was performed as homogeneous SPA-assay (scintillation proximity assay) using the assay buffer 50 mM TRIS-HCl, 10 mM M... |
US Patent US10807989 (2020)
BindingDB Entry DOI: 10.7270/Q2222XTM |
More data for this
Ligand-Target Pair | |
Search and Browse
